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Introduction {#sec1}
============

A mere 10% of the adult American population consume the estimated average requirements (EARs) of vitamin E (vitE) (∼15 mg/day α-tocopherol \[α-TOH\]) ([@bib21], [@bib45], [@bib41]). Severe vitE deficiency stemming from liver diseases, extensive intestinal resections, and the inherited disease of vitE deficiency termed "ataxia with vitE deficiency" (AVED) result in profound ataxia ([@bib47]). Prevailing functions of vitE have been ascribed to the maintenance of typical neurologic structure and function. Despite identification of vitE as an essential food nutrient ([@bib8]), the molecular, cellular, and functional mechanisms of vitE remain debated. There is extensive evidence supporting the role of vitE, specifically α-tocopherol (α-TOH), as a lipid-soluble antioxidant *in vitro* ([@bib49]) and *in vivo* ([@bib13], [@bib44]), and this has been suggested to be the primary functional mechanism of biologic activity ([@bib59]). Besides this well-established role as an inhibitor of lipid peroxidation, other non-antioxidant properties of α-TOH have been identified, including transcriptional regulation and cell signaling ([@bib3]).

AVED results from mutations in the α-tocopherol transfer protein gene (*TTPA*) ([@bib26], [@bib70]). Phenotypic variability is due the location of the genetic mutation within *TTPA,* the amount of vitE in the daily diet, and the time of initiation and dosage of vitE supplementation ([@bib4], [@bib14]). Most patients demonstrate symptoms of AVED between 4 and 18 years of age ([@bib11], [@bib26], [@bib55]). Patients with AVED exhibit ataxia, areflexia, decreased fine touch, and vibration discrimination ([@bib26], [@bib55]). Histologic hallmarks of AVED include axonal swellings within the dorsal column medial lemniscus pathway, the sensory pathway that conveys sensations of fine touch vibration, two-point discrimination, and proprioception from the skin and joints. Of note, lesions in the gracile system of the medulla oblongata are also features of physiologic neuroaxonal aging across many species ([@bib7]). Chronic vitE, specifically α-TOH, deficiency slowly accelerates brain lipid peroxidation and results in cognitive impairment in mice ([@bib20]) and zebrafish ([@bib44]). These deficits can be partially restored by vitE supplementation, in the form of α-TOH. Indeed, early α-TOH supplementation in patients with AVED may suppress severe disease symptoms by unknown mechanisms ([@bib1]).

*Ttpa*^*−/−*^ mice represent an accepted model that recapitulates the phenotype of AVED, with ataxia and histologic lesions, including reduction of myelinated fibers in the gracile fasciculus and chromatolysis of neurons within the nucleus gracilis, as early as 6 months of age ([@bib17]). By 17 months of age, diminished dendritic branching of Purkinje neurons within the cerebellum is evident ([@bib61]). The affected somatosensory tracts originate in the dorsal root ganglia (DRG), with apoptosis of DRG neurons (DRGNs) evident by 12 months of age ([@bib17]). Therefore, it has been suggested that the most pronounced neurologic deficit in *Ttpa*^*−/−*^ mice is loss of proprioception. This proprioceptive loss and associated pathology in the spinal cord and cerebellum can be prevented by supplementation of *Ttpa*^*−/−*^ mice at weaning with 17x the amount of dl-α-tocopheryl acetate (600 mg/kg feed) ([@bib17]). These studies demonstrate that the interaction of genotype, dietary vitE concentration, and time point in postnatal development are crucial to the development of the neurologic phenotype.

To investigate the underlying mechanisms of functional alterations with vitE deficiency, single-cell RNA-sequencing (scRNA-seq) was performed within the DRG of *Ttpa*^*−/−*^ mice. We hypothesized that the most profound transcriptional dysregulation with vitE deficiency would occur in large-diameter myelinated proprioceptive DRGNs. Therefore, we sought to (1) define the transcriptional dysregulation within DRGN subpopulations in *Ttpa*^*−/−*^ mice and (2) identify alterations in membrane electrical properties within the targeted DRGN subpopulations of *Ttpa*^*−/−*^ mice.

Results {#sec2}
=======

Single-Cell RNA-Sequencing Defines Specific DRGN Subpopulations {#sec2.1}
---------------------------------------------------------------

To determine the molecular mechanisms leading to sensory deficits in vitE-deficient DRGNs, scRNA-seq was performed on neuronal cells collected from the DRG (between cervical \[C1\] and lumbar \[L6\] vertebrae) of mice in three experimental groups: (1) *Ttpa*^*+/+*^ on a basal vitE diet (vitE+; WT), (2) *Ttpa*^*−/−*^ on vitE-deficient diet (DEF), and (3) *Ttpa*^*−/−*^ on vitE-supplemented diet (SUPP) at 6 months of age ([Table S1](#mmc2){ref-type="supplementary-material"}; see [Methods](#sec4){ref-type="sec"} for dietary vitE levels). We have previously identified clinicohistologic evidence of the ataxic phenotype by 6 months of age and completed whole tissue transcriptomic profiling of spinal cord and cerebellum at this time point ([@bib17]). In that study, we identified only minor differences between *Ttpa*^*−/−*^ mice maintained on a basal diet (i.e. 35 mg of dl-α-tocopheryl acetate/kg feed) and *Ttpa*^*−/−*^ mice on a vitE-deficient diet (DEF; \<10 mg of dl-α-tocopheryl acetate/kg feed). Instead, a highly supplemented vitE diet (SUPP; 600 mg of dl-α-tocopheryl acetate/kg feed) was required to prevent the AVED phenotype. Therefore, in the current study, we focused our comparisons on DEF vs. WT and DEF vs. SUPP mice. Contrasts included (1) WT vs. DEF, to determine gene expression changes associated with severe vitE deficiency in DRGNs; (2) SUPP vs. DEF to determine the biologic mechanisms whereby the clinicopathologic AVED phenotype is prevented; and (3) SUPP vs. WT to identify any remaining dysregulated pathways following high-dose vitE supplementation in *Ttpa*^*−/−*^ mice. As high-dose vitE supplementation does not restore brain α-TOH to WT concentrations ([@bib17], [@bib69]), we postulated that any gene dysregulation within the SUPP vs. WT group may provide insight into this phenomenon.

ScRNA-seq was performed on an average of 3,614 ± 470 DRGN from two replicate mice per group, with a total of 382 million (M) reads generated (17,862 ± 2,625 reads/cell). Approximately 66.5% of reads mapped to the murine transcriptome, similar to previous reports ([@bib62]), and an average of 1,788 ± 283 genes detected per cell, with no difference between experimental groups ([Figure S1](#mmc1){ref-type="supplementary-material"}).

Unsupervised single-cell transcriptome profiling identified 14 initial subpopulations in all mice, using gene profiles as previously reported ([Figures 1](#fig1){ref-type="fig"}A and [S2](#mmc1){ref-type="supplementary-material"}A) ([@bib62], [@bib38]). Based on further evaluation of subpopulations 0 and 2, both clusters appeared to contain peptidergic neurons and were, therefore, merged into cluster 0.2 ([Figure S2](#mmc1){ref-type="supplementary-material"}B). The top transcripts in each subpopulation are provided in [Table S2](#mmc1){ref-type="supplementary-material"}. A t-distributed stochastic neighbor embedding (t-SNE) plot identified a small number of neuronal cells that could not be classified based on previously reported gene profiles ([Figure S2](#mmc1){ref-type="supplementary-material"}A). This cluster was labeled as "Unassigned." Each DRG subpopulation set contained differentially expressed genes characteristic for that cluster. These clusters were classified as PEP1, PEP2, NP1, NP2, NP2-2, NP3, NF1, NF2, NF3, NF4-5, TH1, and TH2 as previously described ([@bib62]) and "Unassigned" for the unassigned cluster ([Table S2](#mmc1){ref-type="supplementary-material"}). There were no significant differences in cell count per neuronal cluster across experimental groups (p\> 0.05 in each subpopulation) ([Table S1](#mmc2){ref-type="supplementary-material"}). A distinct population of microglial cells based on previously reported markers was not identified ([Figure 1](#fig1){ref-type="fig"}A). Although previous studies have identified outliers or cells with unresolved identity, we further evaluated the "Unassigned" DRGN subpopulation using the top 15 transcripts defining this cluster ([Figure S2](#mmc1){ref-type="supplementary-material"}A, [Table S2](#mmc1){ref-type="supplementary-material"}). Two of the most specific transcripts representing this cluster, forkhead box protein transcription factor 2 (*Foxp2*) and olfactomedin 3 (*Olfm3*), have been previously identified in DRG, primarily in postnatal mice through P14 ([@bib31], [@bib48]). However, these transcripts are also present in adult brain ([@bib16], [@bib48], [@bib54]). Therefore, this subset of neurons most likely represents the small number of remaining developmental neurons undergoing axonal growth.Figure 1An Overall Increase in the Number of Differentially Expressed Transcripts across All DRGN Subpopulations with α-TOH Deficiency(A) A t-distributed stochastic neighbor embedding (t-SNE) plot of merged datasets of the six experimental mice to define neuronal subpopulations clusters. Thirteen clusters were identified based on previously reported gene expression profiles ([@bib38], [@bib62]). The "NP2-2" subgroup contained some genes representative of the NP2 cluster but was distinct from the NP2 cluster and has been previously characterized ([@bib62], [@bib38]).(B) An increasing number of significantly (*P*~FDR~\<0.05) differentially expressed transcripts (DETs) was identified in each DRGN subpopulation with increasing contrasts of vitE deficiency (i.e. SUPP vs. DEF \> WT vs. DEF \> SUPP vs. WT).(C and D) (C) The two most commonly dysregulated transcripts across DRGN subpopulations were carbonic anhydrase 8 (*Car8*), which was significantly downregulated in 10/13 DRG clusters with vitE deficiency (SUPP vs. DEF), and (D) the lineage-specific transcription factor *Runx3*, which was significantly upregulated in 10/13 DRG clusters with vitE deficiency (SUPP vs. DEF). p values were adjusted by a false discovery rate of 0.05 and log-transformed. Significance was set at *P*~FDR~\<0.05, corresponding to a --log *P*~adjusted~\>1.3 (red line). NF = neurofilament, NP = non-peptidergic, PEP = peptidergic, TH = tyrosine hydroxylase, UNKNOWN = unknown cluster, n = 2 mice per group with \~3,600 cells/mouse profiled.

An Increasing Number of Dysregulated Transcripts with Increasing vitE Deficiency {#sec2.2}
--------------------------------------------------------------------------------

Within each neuronal cluster, dysregulated transcripts were identified between WT vs. DEF, SUPP vs. WT, and SUPP vs. DEF. For each cell subpopulation, at least two-fold dysregulated (i.e. up- or downregulated at *P*~FDR~\<0.05) transcripts were identified between vitE treatment groups (i.e. SUPP vs. DEF ≫ WT vs. DEF \> SUPP vs WT) ([Figure 1](#fig1){ref-type="fig"}B, [Tables S3](#mmc1){ref-type="supplementary-material"} and[S4](#mmc3){ref-type="supplementary-material"}). The greatest degree of dysregulation in the SUPP vs. DEF group was apparent in the NP1 and TH2 subpopulations ([Figure 1](#fig1){ref-type="fig"}B).

Top Dysregulated Transcripts across the Majority of DRG Subpopulations: *Car8* and *Runx3* {#sec2.3}
------------------------------------------------------------------------------------------

When WT and SUPP were compared with the DEF groups, carbonic anhydrase 8 (*Car8*)*,* encoding for a protein that inhibits inositol trisphosphate receptor 1 (IP~3~R1) ([@bib73]), was significantly (*P*~FDR~\<0.05) downregulated in 10/13 DRG clusters ([Figure 1](#fig1){ref-type="fig"}C). In particular, *Car8* was the top downregulated transcript with vitE deficiency in the four neurofilament subgroups (NF1, NF2, NF3, and NF4/5). *Car8* was downregulated in these subgroups even in the SUPP vs. WT contrast ([Figure 1](#fig1){ref-type="fig"}C). The lineage-specific transcription factor *Runx3* was significantly (*P*~FDR~\<0.05) upregulated in 10/13 DRG clusters when comparing WT and SUPP vs. DEF groups, especially within NP3 and TH2 ([Figure 1](#fig1){ref-type="fig"}D). Even within the SUPP vs. WT contrast, *Runx3* remained significantly upregulated in 8/13 DRG subpopulations, including NP3 and TH2 ([Figure 1](#fig1){ref-type="fig"}D).

As Car8 is the primary inhibitor of IP~3~R1 ([@bib29], [@bib30]) and transcription of *Car8* was significantly downregulated with vitE deficiency, we postulated that IP~3~R1 signaling might be affected by the level α-TOH supplementation. In DEF mice, a pronounced decrease in IP~3~R1 was apparent in TH+ DRGNs, whereas protein levels appeared increased in SUPP mice ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Similarly, Car8 was increased in TH+ DRGNs in the SUPP group ([Figure S3](#mmc1){ref-type="supplementary-material"}B).

Profound Upregulation of Voltage-Gated Ca^2+^ and K^+^ Channels in TH+ DRGNs {#sec2.4}
----------------------------------------------------------------------------

Modulation of Ca^2+^ channel activities mediate changes in neuronal plasticity and, when upregulated, promote neurodegeneration ([@bib12]). Transcripts associated with both ligand-gated and voltage-gated Ca^2+^ and K^+^ channels were evaluated across genotype and vitE diet groups in our scRNA-seq dataset ([Table S5](#mmc1){ref-type="supplementary-material"}). When comparing SUPP vs. DEF groups, of the voltage-activated Ca^2+^ channels expressed in DRGNs, intermediate-voltage Ca~v~2.3 (*Cacna1e;* TH1 *P*~FDR~ = 1.51 x 10^−8^, TH2 *P*~FDR~ = 1.29 x 10^−11^) channel was most notably upregulated in TH+ DRGNs ([Figure 2](#fig2){ref-type="fig"}A). High-voltage-activated P-type Ca^2+^ channel, *Cacna1a,* was not significantly altered in any DRGN subpopulation, whereas N-type Ca^2+^ channel, *Cacna1b,* was only upregulated in the NP1 DRGN subpopulation of the SUPP vs. DEF groups (*P*~FDR~ = 0.001) ([Table S5](#mmc1){ref-type="supplementary-material"}). When evaluating K^+^ channel transcripts significantly (*P*~FDR~\< 0.05) upregulated in the SUPP vs. DEF groups, the most commonly affected DRGN subpopulations for K^+^ voltage-gated channel transcript upregulation were TH+ ([Table S5](#mmc1){ref-type="supplementary-material"}). In particular, regulatory subunits of the large-conductance Ca^2+^-activated channel subfamily M (*Kcnmb1;* TH1 *P*~FDR~ = 0.009, TH2 *P*~FDR~ = 1.68 x 10^−4^ and *Kcnmb2;* TH1 *P*~FDR~ = 0.017, TH2 *P*~FDR~ = 5.20 x 10^−5^) were upregulated in TH+ DRGNs ([Figure 2](#fig2){ref-type="fig"}B). Although a few of the transcripts encoding voltage-gated K^+^ channels were upregulated in TH+ DRGNs, most transcripts in this family were upregulated in the non-peptidergic DRGNs ([Table S5](#mmc1){ref-type="supplementary-material"}).Figure 2Upregulation Intermediate Voltage-Gated Ca^2+^ and K^+^ Channels in TH+ DRGNs with vitE DeficiencyHeatmaps, plotted by --log*P*~adjusted~, comparing the degree of upregulation for R-type intermediate voltage-gated Ca^2+^, *Cacna1e,* and Ca^2+^-activated K^+^ channel beta subunits channels, *Kcnmb1* and *Kcnmb2,* in DRGN subpopulations with vitE deficiency. Contrast A = SUPP vs. WT, contrast B = WT vs. DEF, contrast C = SUPP vs DEF. *Cacna1e=* Cav2.3 intermediate voltage-activated Ca^2+^ channel, *Kcnmb* = Potassium large conductance calcium-activated channel, subfamily M, beta.

Increase in Cacna1e and Kcnmb2 with vitE Deficiency in TH+ DRG {#sec2.5}
--------------------------------------------------------------

To confirm that Ca~v~2.3 (*Cacna1e*) and regulatory subunits *Kcnmb1* and *Kcnmb2* were indeed upregulated, we further evaluated mRNA and protein levels of Cacna1e and Kcnmb2. In DEF mice, there was a pronounced increase in *Cacna1e* and *Kcnmb2* in TH+ DRGNs at the level of both mRNA ([Figures 3](#fig3){ref-type="fig"}A, 3C, and 3E) and respective proteins ([Figures 3](#fig3){ref-type="fig"}B and 3D).Figure 3Increase in Cacna1e and Kcnmb2 with vitE Deficiency in TH+ DRG(A--D) Green: Th, Blue: DAPI nuclei, Red: Cacna1e \[(A) mRNA, (B) protein\] and Kcnmb2 \[(C) mRNA, (D) protein\]. White box inset magnified in the last column. Fluorescent immunohistochemistry from 4-month WT, DEF, and SUPP mice, n = 1--2 per group. Scale bars represent 10 μm (TH, Cacna1e, Kcnbm2, and merge) and 3 μm (enlarged).(E) Quantification of mRNA using RNAscope for *Cacna1e* and *Kcnmb2*. Mean ± SD, N = 8 counts per experimental group, one-way ANOVA, or Kruskal-Wallis. Scale bars represent 10 μm (TH, Cacna1e, Kcnbm2, and merge) and 3 μm (enlarged).(F) Von Frey assay, demonstrating a significant increase in sensitivity (i.e. lower Dixon\'s score) in the SUPP vs. DEF mice. Mean ± SD, N = 8--22 per group, one-way ANOVA, \*\*\*\*p\< 0.0001, \*\*p\< 0.01, \*p\< 0.05.

Supplementation with High-Dose α-TOH Increased Mechanical Sensitivity in *Ttpa*^*−/−*^ Mice {#sec2.6}
-------------------------------------------------------------------------------------------

The von Frey filament assay was performed as previously described ([@bib43]). SUPP mice had significantly increased mechanical sensitivity compared with DEF diet (*P*~*adjusted*~ = 0.007, [Figure 3](#fig3){ref-type="fig"}F).

Altered Excitability of *DEF* Small-Diameter DRGNs {#sec2.7}
--------------------------------------------------

To understand the etiology and mechanisms of DRG neuronal responses, sensory deficits, and degeneration in AVED as shown in *Ttpa*^*−/−*^ mice ([@bib17], [@bib69]), we focused on the changes in membrane electrical properties. First, we focused on identifying small-diameter mechanosensitive DRGNs. We applied displacement-clamp at DRGN cell-bodies. Using a holding potential of −70 mV, mechanical displacement of the small-diameter DRGN cell body evoked inward currents ([Figure 4](#fig4){ref-type="fig"}A, inset shows traces from WT DRGN). The mechanically activated (MA) current (I~MA~) had amplitudes ranging from 75 to 500 pA (*n* = 11; [Figure 4](#fig4){ref-type="fig"}A). The displacement-response relationships from data from WT DRGNs were fitted with a single Boltzmann function with half-maximal activation displacement (X~1/2~) and slope factor of 1.1 ± 0.1 μm and 0.3 ± 0.1 μm (*n* = 11; [Figure 4](#fig4){ref-type="fig"}A). Similar data from *DEF* DRGNs for X~1/2~ and slope factor were 1.5 ± 0.1 μm and 0.4 ± 0.1 μm (n = 7). Unpaired *t*test comparison shows significant differences in the X~1/2~ (p = 0.016) but not the slope factor (p = 0.51) between the WT and DEF DRGNs. The rightward shift in the displacement-response relations in the DEF DRGNs suggest a decrease in mechanical sensitivity.Figure 4Membrane Properties of Small-Diameter Dorsal Root Ganglion Neurons (DRGNs) from WT and DEF MiceCurrent-clamp recordings were performed on DRGNs 6-month-old mice. Membrane input resistance (R~i~) was determined by evaluating membrane voltage changes in response to negative and positive current injection. The ohmic relations were fitted with linear regression and the R~i~ derived from the slope.(A) Representative traces of displacement-clamp currents recorded using CsCl/NMG-based pipette solution in response to \~250-ms mechanical displacement steps of \~0.42 μm to WT small-diameter DRGN (shown as inset). DRGNs were held at −70 mV. Summary data of displacement-response relationship of mechanically activated (MA) currents (I~MA~) represented as the I/I~max~ or open channel probability (P~o~) against displacement (X) fitted with single Boltzmann function. Data from WT DRGNs (shown in black symbols and fitted with sigmoidal curve in black) and the one-half maximum displacements (X~1/2~) are 1.1 ± 0.1 μm and 0.3 ± 0.1 μm (*n* = 11). Data from DEF DRGNs (shown in blue symbols and fitted with sigmoidal curve in blue) and the one-half maximum displacements (X~1/2~) are 1.5 ± 0.1 μm and 0.4 ± 0.1 μm (*n* = 7).(B) Among the small-diameter neurons, there were three distinct classes: fast, medium, and slow adapting. Exemplary plots from fast-adapting DRGNs from WT mice (shown in black, mean R~i~ in MΩ; 100 ± 6; n = 15), and in DEF (shown in blue, mean R~i~ in MΩ; 45 ± 5; n = 17: p\< 0.0001). The inset is an example of data used to generate the plots. For medium-adapting neurons the R~i~ (in MW) were as follows: WT (306 ± 23; n = 9) and DEF (162 ± 29; n = 11: p = 0.0014). For slow-adapting neurons the R~i~ were WT (626 ± 47; n = 13) and DEF (395 ± 38; n = 11: p = 0.0012).(C) Brief (\~5 ms) stepwise positive current was injected to elicit subthreshold (shown in different color codes) and threshold depolarization (WT in black and DEF in blue). The threshold currents are indicated. The threshold voltage was determined, using a dV/dt loop plot (inset, right).(D and E) Typical voltage response from slow-adapting DRGNs recorded from WT and DEF mice.(F and G) Action potentials generated using varying pulse durations from fast-adapting DRGNs in WT (F) and DEF (G) mice.(H) Plots of the relations between threshold potential and pulse duration in WT (in black) and DEF (in blue) mice. The insets show the dV/dt *versus* membrane potential (V) loops used to determine the thresholds.

Three functional classes of neurons were then assessed based on their evoked spike frequency adaptation kinetics, defined as fast (eliciting 1--2 APs for ∼0.5-s suprathreshold current injection), medium (4--6 APs), and slow (\>10 APs) adapting neurons. We first compared WT with DEF DRGNs. On average, the input resistances of the three classes of neurons in WT were ∼2-fold greater than the DEF neurons. [Figures 4](#fig4){ref-type="fig"}B and 4C summarize exemplary steady-state input resistances (R~i~, in MΩ), of the WT (black; 100 ± 6; n = 15), with ∼0.33 nA required to elicit an AP and DEF (blue; 45 ± 5; n =17), with ∼0.73 nA being the AP threshold for fast-adapting DRGNs. For medium-adapting neurons, the R~i~ were WT (306 ± 23; n = 9) and DEF (162 ± 29, = 11), and for slow-adapting neurons the R~i~ were WT (626 ± 47; n = 13) and DEF (395 ± 38; n = 11). The intrinsic membrane properties of the small-diameter DRGNs suggested that membrane excitability was reduced in DEF mice. In agreement with this assertion, DEF slow-adapting DRGNs showed profound attenuation in spike activity in response to current injection compared with WT DRGNs ([Figures 4](#fig4){ref-type="fig"}D and4E). AP thresholds for fast-adapting DRGNs were determined by calculating dV/dt, as illustrated in [Figure 4](#fig4){ref-type="fig"}C (right panel), and the sensitivity of neurons were tested using the indicated pulse duration. For WT DRGNs, with increasing pulse duration, the threshold voltage amplitude declined in a monotonic fashion. However, for DEF DRGNs, the threshold voltage had a biphasic response relative to pulse duration ([Figures 4](#fig4){ref-type="fig"}F--4H).

Increased K^+^ and Ca^2+^ Density in *DEF* Small-Diameter DRGNs {#sec2.8}
---------------------------------------------------------------

The underlying conductances responsible for the reduced R~i~ and membrane excitability in the small-diameter *Ttpa*^*−/−*^ DRGNs were examined in the voltage-clamp configuration. Ca^2+^ and K^+^ currents were isolated under conditions where other ion channel conductances were suppressed. The rationale for focusing on these Ca^2+^ and K^+^ conductances stemmed from the scRNAseq analyses ([Figures 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}). Whole-cell voltage-clamp of the small-diameter mechanosensitive DRGNs showed outward K^+^ currents with transient and sustained components in both WT ([Figure 5](#fig5){ref-type="fig"}A, upper panel, black) and DEF ([Figure 5](#fig5){ref-type="fig"}A, lower panel, blue) mice in response to varying voltage steps (−110 to 40 mV) from a holding potential of −90 mV in 10-mV increments. The difference-current traces plotted in dashed lines (inset) provide the profile of the enhanced outward K^+^ current in the DEF DRGNs. This difference in currents consisted of mainly a sustained outward current. The total outward K^+^ current density plotted as a function of voltage showed significant differences in current densities elicited at −30 to 40 mV step voltages comparing data between WT and DEF mice (n = 17; p\< 0.05, [Figure 5](#fig5){ref-type="fig"}B). To examine Ca^2+^ currents, we suppressed outward K^+^ currents, by substituting pipette and bath K^+^ with NMDG^+^ and Cs^+^ (see [Methods](#sec4){ref-type="sec"}). Inward Na^+^ current contamination of Ca^2+^ currents was suppressed using TTX (1 μM) and by partial substitution of bath Na^+^ with NMDG. Ca^2+^ currents were activated using −90 and −40 mV holding voltages, and varying step voltages were applied from −120 to 40 mV. Ca^2+^ currents in DRGN consist of multiple components: low- and high-voltage-activated currents ([@bib5], [@bib65]). The difference-current derived by subtracting current traces generated from −40 mV and that at −90 mV holding potentials yielded mainly the transient and low-voltage activated components ([Figures 5](#fig5){ref-type="fig"}C and 5D). Summary data from current-voltage relations show that the high-voltage-activated Ca^2+^ currents were enhanced in DEF DRGNs ([Figure 5](#fig5){ref-type="fig"}E). As shown in the inset and illustrated in the current-voltage, rSNX-482 (500 nM), a Ca~v~2.3 (R-type) current-specific blocker ([@bib66]), suppressed a component of the Ca^2+^ current. Additionally, in three recordings from DEF DRGNs, in which rSNX-482 was applied in the bath solution, the enhanced current was attenuated, suggesting the current was conducted by Ca~v~2.3 channels ([@bib10], [@bib66]).Figure 5Increased K^+^ and Ca^2+^ Current Density in DEF versus WT DRGNs(A)Whole-cell onward K^+^ currents were elicited using depolarizing steps from −110 to 40 mV (ΔV = 10 mV). The tail currents were at −40 mV. Current traces recorded from WT and DEF DRGNs are shown in black and blue, respectively. To obtain a profile of currents that are enhanced in DEF DRGNs, we determined the "difference currents" between DEF and WT neurons at −70 and 40 mV step voltages (traces are plotted with dashed lines in inset).(B) Summary of steady-state currents was normalized to individual membrane capacitance (C~m~), from 6-month-old WT mice (shown with black line and symbol) and *DEF* (shown with gray traces). Data were generated from 14 DRGNs from each experimental group. The mean current densities (in pA/pF) in WT and DEF DRGNs at 0 mV step voltage were 26.1 ± 2.6 and 39.9 ± 2.8; n = 14, p = 0.0015.(C and D) Inward Ca^2+^ currents recorded from a 12-pF DRGNs in WT (in black) and DEF (in blue) mice from −90 and −40 mV holding potentials. Currents were generated using voltage steps ranging from −110 to 40 mV. The difference-current traces (−90 mV) - (−40 mV) are plotted in dashed lines as an inset.(E) Peak Ca^+^ current density (I)-voltage (V) relation from data amassed from 12 DRGNs in each group. The current densities generated from a holding voltage of −40 mV are plotted with WT in black and DEF in blue. The high-voltage activated component of the Ca^2+^ current was enhanced in the DEF DRGNs. The peak current density (in pA/pF) for currents elicited from a holding potential of −40 mV for WT DRGNs was 20.1 ± 1.5 (n = 9) and for DEF DRGNs was 30.9 ± 2.5 (n = 9, p = 0.002). After application of 500 nM rSNX-482 to the DEF DRGNs the peak current density plummeted to 12.6 ± 1.2 (n = 6, p\< 0.0001).

Since high-dose vitE supplementation on DEF DRGN appeared to restore the molecular and cellular hallmarks of vitE deficiency, we examined the membrane properties of small-diameter DRGNs in SUPP mice. We examined sensitivity of SUPP DRGNs to mechanical displacements as described in [Figure 4](#fig4){ref-type="fig"}A. The displacement-response relationships from data from SUPP DRGNs were fitted with a single Boltzmann function (shown in green) with half-maximal activation displacement (X~1/2~) and slope factor of 1.09 ± 0.1 μm and 0.3 ± 0.1 μm (*n* = 6; [Figure 6](#fig6){ref-type="fig"}A). We superimposed data from WT (in black) and DEF (in blue) DRGNs for comparison. A one-way ANOVA was performed to compare the X~1/2~ and the slope factor in WT, DEF, and SUPP DRGNs displacement-response curves. There were significant differences at the p\< 0.05 level for the three conditions (X~1/2~ F(2,21) = 6.088, p = 0.008). Post-hoc comparisons using the Tukey HSD test indicated that data from WT and DEF (p = 0.011) as well as DEF and SUPP (p = 0.024) are significantly different. There was no significant difference between WT and SUPP. Additionally, there were no significant differences in the slope factor in the three experimental conditions.Figure 6Membrane Properties of Small-Diameter Dorsal Root Ganglion Neurons (DRGNs) from SUPP Mice(A) Current-clamp recordings were performed on DRGNs 6-month-old mice supplemented with 600 mg dL-alpha-tocopheryl/kg feed. Data were assessed from DRGNs with capacitance \<15 pF. Membrane input resistance (R~i~) was determined by evaluating membrane voltage changes in response to negative and positive current injection.(B) The ohmic relations were fitted with linear regression and the R~i~ derived from the slope. SUPP mice fast-adapting DRGNs had a mean R~i~ of 115 ± 9 MW (n = 11).(C) Similar to WT DRGNs, as the pulse duration was prolonged, the threshold voltage declined.(D) Typical voltage response from slow-adapting DRGNs recorded from SUPP mice. Compared with WT DRGNs, the slow-adapting neurons in SUPP did not recover fully despite vitE supplementation.(E)Whole-cell onward K^+^ currents were elicited using depolarizing steps from −130 to 30 mV (ΔV = 10 mV), from a holding potential of −90 mV. The tail currents were at −60 mV. Current traces recorded from SUPP DRGNs are shown.(F) Summary of steady-state currents was normalized to individual membrane capacitance (C~m~), from 6-month-old SUPP mice. Data were generated from 15 DRGNs.(G and H) Inward Ca^2+^ currents recorded from a 10-pF DRGNs in SUPP mice from −90 and −40 mV holding potentials. Currents were generated using voltage steps ranging from −120 to 40 mV.(I) The current-voltage relations generated at −90 mV and −40 mV holding potential is plotted. The I-V relations of Ca^2+^ currents from DEF DRGNs from [Figure 5](#fig5){ref-type="fig"}E is re-plotted in blue for comparison.

Excitability of *SUPP* Small-Diameter DRGNs {#sec2.9}
-------------------------------------------

For SUPP mice, fast-adapting DRGNs had a mean R~i~ 115 ± 9 MΩ (n = 11) ([Figure 6](#fig6){ref-type="fig"}B, shown with green symbols and line). The R~i~ between WT (in black line), DEF (in blue line), and DRGNs ([Figure 4](#fig4){ref-type="fig"}B) is replotted for comparison. There were significant differences at the p\< 0.05 level for the three conditions (F(2,40) = 174.7, p = 0.001). Post-hoc comparisons using the Tukey HSD test indicated that R~i~ from WT vs. DEF (p = 0.001), WT vs. SUPP (p = 0.001), and DEF vs. SUPP (p = 0.001) are significantly different. Similar to WT DRGNs, as the pulse duration was prolonged, the threshold voltage amplitude declined ([Figure 6](#fig6){ref-type="fig"}C). However, the apparent preventative effects of vitE supplementation were not visibly seen in the slow-adapting small-diameter DRGNs. Compared with WT DRGNs, the slow-adapting neurons in SUPP did not recover fully despite vitE supplementation ([Figure 6](#fig6){ref-type="fig"}D). We examined whole-cell onward K^+^ currents by applying depolarizing voltage steps from −130 to 30 mV (ΔV = 10 mV), from a holding potential of −90 mV in SUPP DRGNs ([Figure 6](#fig6){ref-type="fig"}E). The steady-state outward K^+^ currents normalized to individual membrane capacitance (C~m~) ([Figure 6](#fig6){ref-type="fig"}F) showed that vitE supplementation is sufficient to restore the outward K^+^ current (plotted in green and compared with the mean data from WT \[in black\] and DEF \[in blue\]) (see [Figure 5](#fig5){ref-type="fig"}B). For example, the total outward current density elicited at 0 mV in SUPP DRGNs was 24.7 ± 2.9 pA/pF (n = 11). There were significant differences at the p\< 0.05 level for the three conditions; steady-state K^+^ current elicited at 0 mV F(2,36)= 47.6, p = 0.001. Post-hoc comparisons using the Tukey HSD test indicated that WT vs. DEF (p = 0.001) and DEF vs. SUPP (p = 0.001) are significantly different. There is no significant difference between WT vs. SUPP (p = 0.58). We recorded inward Ca^2+^ currents from ∼10-pF DRGNs in SUPP mice using −90 and −40 mV holding voltages. Currents were generated using voltage steps ranging from −120 to 40 mV ([Figures 6](#fig6){ref-type="fig"}G and 6H). The current-voltage relations generated at −90 mV and −40 mV holding voltages are plotted, and the data suggest that vitE supplementation seemingly reversed the enhanced high-voltage-activated Ca^2+^ current observed in DEF DRGNs ([Figure 6](#fig6){ref-type="fig"}I). Summary data from DEF DRGNs in [Figure 5](#fig5){ref-type="fig"}E (in blue) is replotted for comparison.

Upregulation of Pro-apoptotic Transcripts with vitE Deficiency {#sec2.10}
--------------------------------------------------------------

Based on previous studies ([@bib17]), evidence exists for increased apoptosis in the DRGNs with vitE deficiency by 1 year of age in DEF mice. In both the TH2 (*P*~FDR~ = 1.13 x 10^−4^) and NP1 (*P*~FDR~ = 0.01) DRGN subpopulations, apoptosis-inducing factor, mitochondrion-associated 3 (*Aifm3*), was upregulated with vitE deficiency (WT vs. DEF and SUPP vs. DEF; [Figure S4](#mmc1){ref-type="supplementary-material"}A). Additionally, tumor necrosis factor receptor superfamily, member 21 (*Tnfrsf21*), which promotes apoptosis by release of cytochrome *c* from the mitochondria into the cytoplasm, was significantly upregulated in the NP2 (*P*~FDR~ = 2 x 10^−4^) and TH2 (*P*~FDR~ = 0.008) DRGN subpopulations (SUPP vs. DEF; [Figure S4](#mmc1){ref-type="supplementary-material"}A). These results suggest that molecular signatures of apoptosis, most pronounced in TH+ DRGNs, occur by 6 months of age in DEF mice.

To further investigate the pathways leading to apoptosis of DRGNs with vitE deficiency by 1 year of age ([@bib17]), and the potential preference for TH+ DRGNs, protein expression of total and cleaved caspase 3, caspase 8, and caspase 9 was evaluated with both immunohistochemistry and Western blot analyses in 4-month-old mice. There was no evidence of total caspase 3, caspase 8, or caspase 9 activation (data not shown). However, a significant (p\< 0.01) increase in cleaved caspase 3 and caspase 9, localized to TH+ DRGNs, was apparent in DEF mice ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C). There was no evidence of cleaved caspase 8 activation ([Figure S4](#mmc1){ref-type="supplementary-material"}D).

Additional Transcript and Pathway Dysregulated with vitE Deficiency {#sec2.11}
-------------------------------------------------------------------

In order to determine if the altered gene expression in the DEF DRGN was modulated by the vitE binding proteins *Ttpa* ([@bib33]) and tocopherol binding protein (*Tap* or *Sec14l2*) ([@bib74]), we interrogated these transcripts in our dataset. *Ttpa* was not expressed in the DRGN dataset. *Sec14l2* was expressed in DRGNs but only differentially expressed between SUPP vs. DEF in the NP1 subpopulation (upregulated in DEF group; *P*~FDR~ = 0.004). Additionally, the scRNA-seq dataset was evaluated for genes encoding enzymes that have been previously found to directly bind to vitE, including protein kinase C (*Prkca*); PH domain and leucine-rich repeat protein phosphatase 2 (*Phlpp2*); cyclooxygenase-2 (Ptgs2); and lipoxygenases 5, 12, and 15 (*Alox5, Alox12,* and *Alox15*) ([@bib15], [@bib74]). *Ptgs2*, *Alox5*, *Alox12,* and *Alox15* were not expressed in DRGN and, although *Phlpp2* was expressed, there were no differences between experimental groups in any DRGN subpopulation. *Prkca* was significantly downregulated in non-peptidergic DEF DRGN subpopulations (NP1, *P*~FDR~ = 0.01; NP2, *P*~FDR~ = 0.001; and NP3, *P*~FDR~ = 0.03) and upregulated in TH+ DRGN subpopulations (TH1, *P*~FDR~ = 0.03 and TH2, *P*~FDR~ = 0.002) when comparing SUPP vs. DEF.

With severe vitE deficiency, degenerative axons are identified within the caudal medulla oblongata and spinal cord with AVED ([@bib71]). Therefore, we interrogated our dataset for dysregulation of transcripts associated with axonal guidance, synaptic plasticity, and myelination. When SUPP were compared with the DEF groups, upregulation of associated transcripts was identified across DRGN subpopulations, with most transcripts upregulated in TH2 DRGNs ([Table S6](#mmc1){ref-type="supplementary-material"}). Myelin basic protein (*Mbp*) was upregulated in 4/13 SUPP vs. DEF DRGNs ([Table S4](#mmc3){ref-type="supplementary-material"}) but was only downregulated in the TH2 subpopulation (*P*~FDR~ = 0.004).

Because Ca^2+^ signaling triggers growth cone development during neurodevelopment ([@bib12]), transcripts associated with Ca^2+^ binding were interrogated in our scRNA-seq dataset. Most Ca^2+^ binding transcripts were most upregulated in TH+ DRGNs with increasing vitE deficiency ([Figure S5](#mmc1){ref-type="supplementary-material"}A, contrast "C").

To further investigate the transcripts expressed among DRGN subtypes and across vitE diet groups, pathway analyses were performed using Panther Pathway overrepresentation analysis (<http://pantherdb.org/>). When WT and SUPP were compared with the DEF groups, the most commonly dysregulated pathways were upregulation of both the heterotrimeric G-protein signaling pathways G~i~α and G~s~α (P00026) and G~q~α and G~o~α (P00027) ([Figures S5](#mmc1){ref-type="supplementary-material"}B andS5C). Significant (*P*~FDR~\< 0.05) upregulation of these two G-protein signaling pathways was identified in 9/13 DRG clusters ([Table S7](#mmc4){ref-type="supplementary-material"}, [Figure S6](#mmc1){ref-type="supplementary-material"}). For many of these analyses, G-protein coupled receptor (GPCR) pathways were also significantly (*P*~FDR~\< 0.05) overrepresented ([Table S7](#mmc4){ref-type="supplementary-material"}).

To further investigate the potential role of enhanced G-protein signaling with vitE deficiency in specific DRGN subpopulations, specific somatosensory genes were evaluated, including G-coupled receptors (GPCRs) and the transient receptor potential vanilloid 1 (*Trpv1*) channel, as recently reviewed ([@bib72]). Associated transcripts were most significantly upregulated in TH+ expressing neurons in the SUPP vs. WT contrast ([Figure S5](#mmc1){ref-type="supplementary-material"}D). These results indicate a positive association between G-protein-coupled receptor transcripts and vitE deficiency, especially in TH+ DRGNs.

Transcripts for GO-Slim biologic processes known to regulate mitochondrial functions were significantly (*P*~FDR~\< 0.05) downregulated in TH+ and NP1 DRG subpopulations ([Table S7](#mmc4){ref-type="supplementary-material"}). This discovery prompted further evaluation of transcripts associated with oxidative phosphorylation. Between 30% and 50% of the transcript of mitochondrial complex I, NADH:ubiquinone oxidoreductase supernumerary subunits (NDUF) were significantly downregulated (*P*~FDR~\< 0.05) in NP1 and TH2 DRG subpopulations with vitE deficiency ([Figure S5](#mmc1){ref-type="supplementary-material"}E, [Table S8](#mmc1){ref-type="supplementary-material"}).

Discussion {#sec3}
==========

Although the antioxidant role of vitE is well established, with evidence to support protection of critical fatty acids during development of the nervous system ([@bib46], [@bib36]), the proposed non-antioxidant roles for this vitamin remain unclear ([@bib24], [@bib2]). Additionally, it remains unclear why, although all central nervous system tissues are α-TOH deficient in the *Ttpa*^*−/−*^ mouse model, the primary clinicopathologic lesions are localized to sensory tracts. Based on the phenotype associated with AVED ([@bib26], [@bib70]) and recapitulated in the *Ttpa*^*−/−*^ mouse model ([@bib69], [@bib17]), we expected a profound shift in the transcriptomic profile of the proprioceptive DRGN subpopulation. Unexpectedly, we instead identified the most pronounced message alterations in NP1 and TH+ DRGNs, responsible for mechanosensation. Both NP1 and TH+ DRGNs are small to medium in diameter and unmyelinated, whereas proprioceptive DRGNs are large-diameter myelinated neurons. Intriguingly, both NP1 and TH+ subpopulations of DRGNs arise from the same developmental lineage for C-fibers, separating into distinct lineages by E16.5--17.5 in the mouse (reviewed in [@bib50]).

Upregulation of intermediate voltage-gated Ca^2+^ and K^+^ channels in SUPP vs. DEF groups ([Figure 2](#fig2){ref-type="fig"}) prioritized the TH+ DRGN subpopulation for further evaluation. Within TH+ DRGNs, Ca^2+^ dysfunction with vitE deficiency was implicated by upregulation of the Ca~v~2.3 (*Cacna1e*) and the Ca^2+^-activated K^+^ channel subunit *Kcnmb2* ([Figure 3](#fig3){ref-type="fig"})*.* These findings, in combination with decreased IP~3~R1 ([Figure S3](#mmc1){ref-type="supplementary-material"}A) and upregulation of G~q~-coupled receptor pathways responsible for the formation of inositol 1,4,5 triphosphate (IP~3~) ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C) in DEF mice, indicate that abnormal Ca^2+^ dynamics in TH+ DRGNs may be central to the etiology of AVED. Additionally, downregulation of Car8 ([Figures 1](#fig1){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}B), a major inhibitor of IP~3~R1 ([@bib29], [@bib30]), indicated coordinated transcriptional changes that could contribute to overactive Ca^2+^ signaling in TH+ DRGNs. Consistent with this interpretation was the observation that acute vitE deficiency (4--6 months) reduced membrane excitability ([Figures 4](#fig4){ref-type="fig"} and [5](#fig5){ref-type="fig"}) and caspase activation ([Figure S4](#mmc1){ref-type="supplementary-material"}), whereas long-term deficiency resulted in apoptosis of DRGNs ([@bib17]). Supplementation with high-dose α-TOH in DEF mice at weaning prevented the transcriptomic and biochemical profiles described, partially prevented the electrophysiological abnormalities of TH+ DRGNs, and significantly improved mechanical sensitivity as assessed from the displacement-response curves ([Figure 6](#fig6){ref-type="fig"}A) and via the von Frey filament assay ([Figure 3](#fig3){ref-type="fig"}F). As peripheral neuropathy is a clinical feature of AVED ([@bib26], [@bib19]), altered Ca^2+^ signaling within mechanosensitive DRGNs could provide a mechanism for loss of peripheral sensation.

Collectively, our findings are the first to link TH+ DRGNs with vitE deficiency and AVED. TH+ DRGNs constitute approximately 10%--15% of all mouse lumbar DRGNs ([@bib9]); are located in haired skin; and are responsive to brush, pressure, and pinch but not temperature ([@bib38]). In patients with AVED, loss of vibration sense and sensitivity to light touch are the frequently reported symptoms ([@bib26]), as the dorsal column medial lemniscal neuroanatomic tract is targeted in vitE deficiency ([@bib17], [@bib70]). Therefore, we postulate that these symptoms may be due to impaired excitability and abnormal Ca^2+^ signaling. Specifically, reduced membrane excitability of mechanosensitive DRGNs could account for the peripheral neuropathy associated with AVED. Supplemental α-TOH has been demonstrated to improve peripheral neuropathy in AVED patients ([@bib42]).

Our findings identify altered Ca^2+^ signaling in TH+ DRGNs with vitE deficiency, in particular, IP~3~R1 pathways. Upregulation of Ca^2+^-binding transcripts, the voltage-gated Ca~v~2.3 (*Cacna1e*) channel, and Ca^2+^-activated K^+^ channel subunit *Kcnmb2* are likely mechanistically interrelated alterations that further contribute to the neuropathology in TH+ DRGNs. First, electrophysiological recordings showed enhanced K^+^ and Ca^2+^ current densities in small-diameter DRGNs isolated from DEF mice. Second, upregulation of GPCRs and downregulation of *Car8* support a role of altered GPCR/phospholipase C (PLC)/inositol triphosphate (IP~3~) signaling in vitE-deficient TH+ DRGNs. Reactive oxygen species can activate G~q~-coupled receptors, catalyzing the conversion of plasma membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP~2~) by PLC to the intracellular secondary molecules IP~3~ and diacylglycerol (DAG) ([@bib56], [@bib63]). As vitE remains the most potent inhibitor of lipid peroxidation ([@bib13], [@bib44], [@bib49]), the protection afforded at the plasma membrane may affect GPCR signaling. The decrease in small-diameter DRGN membrane excitability of DEF mice may, therefore, result from altered Ca^2+^ signaling in TH+ DRGNs. In keeping with reduced excitability of DEF DRGNs, the rate of change of membrane voltage at the upstroke phase of APs (dV/dt) was shallow compared with WT neurons ([Figure 4](#fig4){ref-type="fig"}C), which may implicate alterations in Na^+^ current magnitude and kinetics ([@bib28]). Although there were no significantly dysregulated Na^+^ channel transcripts in the TH+ DRGNs ([Table S4](#mmc3){ref-type="supplementary-material"}), posttranslational modifications of Na^+^ channels may have occurred. Additionally, we cannot determine from this study if the observed effects on membrane excitability are the result of the observed gene expression changes following vitE deficiency or the insufficient vitE concentrations in the DRGNs. Experiments requiring the addition of exogenous α-TOH to DRGNs from DEF mice would be required to determine if membrane excitability can be restored with the addition of vitE. Despite this inability to definitively determine causality, the clinical relevance of these findings indicate that gene expression and membrane excitability changes within the DRGN may underlie the peripheral neuropathy observed with AVED.

By 12 months of age, apoptosis within most large- and small-diameter DRGNs is evident in DEF mice ([@bib17]). Increased TUNEL staining of DRGNs in DEF mice is not observed by 6 months of age (unpublished results). In this study, scRNA-sequencing was performed only on viable cells (see ***Cell count/viability and RNA quality assurance*)*.*** Therefore, within the 6-month DEF mice examined in this study, increased activity of cleaved caspase-3 and -9 in DEF TH+ DRGNs is likely a proximal mechanism of promoting apoptosis.

Using whole tissue spinal cord homogenate, we previously identified altered nuclear receptor activation in DEF mice as they aged from weaning to 6 months ([@bib17]). With sufficient vitE, retinoid orphan-related receptor alpha (RORA)-targeted transcripts were activated in the spinal cord, whereas insufficient vitE led to the activation of liver X receptor (LXR)-targeted transcripts. This effect was not observed in whole-tissue spinal cord when simply comparing groups at 6 months of age (WT vs. DEF vs. SUPP). Similarly, we did not identify upregulation of most previously investigated ([@bib17]) RORA-targeted transcripts in the DRGNs between SUPP and DEF groups at 6 months of age in this current study. Comparison of DRGNs subpopulations in WT, DEF, and SUPP experimental groups between weaning and 6 months of age requires further investigation to fully elucidate the role for RORA with vitE deficiency.

Elevations in 7-oxygenated cholesterol products have been previously described in both the *Ttpa*^*−/−*^ ([@bib17]) and atherosclerotic apolipoprotein vitE-deficient mouse models ([@bib52]). Both 7α-hydroxycholesterol and 7-ketocholesterol are inverse agonists for the constitutively active RORA ([@bib64]). Therefore, we surmise that increased oxysterols suppress constitutive RORA signaling during vitE deficiency, a hypothesis that has been supported by other studies in both the *Ttpa*^*−/−*^ mouse ([@bib23], [@bib22]) and the vitE-deficient horse ([@bib18]). RORA activation is required for synaptic maintenance ([@bib35], [@bib57]) and the neuroprotective effect is mediated by the antioxidant proteins glutathione peroxidase 1 and peroxiredoxin 6 ([@bib6]). Of note, RORA controls the expression of IP~3~R1 ([@bib25], [@bib53]). Therefore, the underlying molecular mechanism whereby vitE deficiency leads to AVED may involve differential nuclear receptor activation with age, leading to altered IP~3~R1 signaling in TH+ DRGNs, in addition to alterations in redox status at the plasma membrane ([Figure 7](#fig7){ref-type="fig"}). Alternatively, specific oxidized polyunsaturated fatty-acid-derived lipid mediators, which are protected by vitE from oxidation and destruction ([@bib13], [@bib36], [@bib37], [@bib60]), may be involved in this protective mechanism.Figure 7Proposed Mechanism of Action for α-TOH in TH+ DRGNWith adequate α-TOH (left), constitutive activity of the RAR-related orphan receptor alpha (RORA) transcription factor is maintained, increasing IP~3~R1 transcription ([@bib25], [@bib53]). Although there is evidence that vitE can affect the plasma membrane structure and bind to signaling enzymes to affect their activity ([@bib74], [@bib27]), we propose in this model that signaling through the PLC/IP~3~/IP~3~R1 axis maintains Ca^2+^ homeostasis. VitE can suppress PLC activity ([@bib15]) and, by stimulating DAGK ([@bib34]), DAG is removed and PKC inhibited, providing a protective effect. With α-TOH deficiency (right), cholesterol is oxidized and resulting oxysterols repress constitutive RORA activity ([@bib64]), leading to decreased IP~3~R1 transcription. ROS activate the PLC/IP~3~/IP~3~R1 axis ([@bib56], [@bib63]); however, without sufficient IP~3~R1, \[Ca^2+^\]~i~ cannot increase. Additionally, loss of DAGK stimulation increases DAG and PKC. We propose this leads to the identified alterations in membrane excitability and activation of apoptotic pathways in DRGNs. BK= big potassium channel; DAG = diaglycerol; DAGK= diaglycerol kinase; IP~3~ = inositol triphosphate; IP~3~R1 = inositol 1,4,5 triphosphate receptor 1; PIP~2~ = phosphatidylinositol 4,5-bisphosphate; PKC = protein kinase C; PLC = phospholipase C; RORA= RAR-related orphan receptor alpha; ROS = reactive oxygen species.

Single-cell RNA-seq generated a total of 382 million reads in our study, with an average of 3,614 DRGNs profiled per mouse (i.e. 7,228 neurons per experimental group). In the pioneer scRNA-seq study of DRG, pooled lumbar DRG were used to generate 2.76 billion reads across 622 single mouse neurons ([@bib62]). A total of 3,574 ± 2,010 distinct genes were identified in each cell ([@bib62]), as compared with our study of 1,788 ± 283 genes per cell. A subsequent publication used neuron-size-based hierarchical clustering and high-coverage scRNA-seq of 203 neurons collected from lumbar DRG of five pooled male mice (10,950 ± 1,218 genes per neuron) ([@bib38]). Despite the overall lower depth of sequencing across genes in our study, we were able to identify the previously characterized ([@bib62]) neuronal subpopulations within the DRG. Previous reports ([@bib62], [@bib38]) clustered the unmyelinated TH+ neuronal population into one population. In our dataset, two distinct TH+ subgroups (TH1 and TH2) were identified across all samples. Despite highly overlapping transcriptional profiles, these subtypes were not closely enough related to merge, unlike the PEP1 subpopulation (i.e. Clusters 0 and 2). The distinct sub-clustering of TH+ subpopulations in our study warrants further investigation, as the most profound alterations with vitE deficiency in our model occurred primarily in the TH2 subpopulation. Our mice were 6 months of age, older than those used in previously reported scRNA-seq profiling studies in DRG ([@bib38], [@bib62]).

The von Frey filament assay is used on glabrous skin, which is innervated by both alpha and beta low-threshold mechanoreceptors, both not TH+ C-low threshold mechanoreceptors ([@bib39]). However, it has been observed that von Frey filament can activate sensitized non-peptidergic type C nociceptive fibers (i.e. NP1 subpopulations) under certain conditions ([@bib51]). In our study, the NP1 subpopulation, responsible for neuropathic pain, was also notably implicated with vitE deficiency. VitE has been demonstrated to act as an analgesic in rodent models of neuropathic pain ([@bib32]), although a more recent study suggests that vitC is required concurrently ([@bib40]). Foot withdrawal thresholds in response to mechanical stimuli were used to assess neuropathic pain followed by spinal cord ligation, with increased thresholds for 6 h after vitE injection ([@bib32]). As neurobehavioral assays through tactile stimuli cannot reliably differentiate different DRGN activities ([@bib39]), we elected to document electrophysiological dysfunction in TH+-specific mechanosensitive DRGNs with vitE deficiency using whole-cell membrane recordings specific to small-diameter mechanosensitive DRGNs. However, further investigation into the role of vitE in NP1 nociceptive DRGNs is warranted.

One of the most notable findings identified in the DEF mouse model is the complete prevention of the clinical and histologic phenotype with high-dose α-TOH supplementation at weaning ([@bib17], [@bib69]). To further support these clinical findings, we have now demonstrated complete prevention of the transcriptomic and partial rescue of the electrophysiologic dysfunction within the DRGNs at the single-cell level. VitE supplementation in *Ttpa*^*−/−*^ mice suffices to partially restore K^+^ and Ca^2+^ current properties in small-diameter mechanosensitive DRGNs, but it remains unclear why slow-adapting DRGNs are impervious to vitE supplementation. Of note, α-TOH concentrations in the brain of these SUPP mice are still significantly lower than those of WT mice ([@bib17], [@bib69]), indicating that α-TTP in the brain functions in maintaining local concentration of α-TOH. Despite the lower brain α-TOH concentrations in SUPP mice compared with WT mice, the AVED clinicohistologic phenotype is completely prevented. Therefore, a minimum concentration of vitE is likely required at this critical time in postnatal development. Even more important is the fact that the phenotype is rescuable when vitE is provided at P21, a time point that is considered the end of postnatal development in the mouse. Therefore, it may be possible that synaptogenesis and axonal elongation continue into adulthood, thereby requiring sufficient vitE from 1--6 months of age in mice.

Although this study focused on DRGNs, vitE has been demonstrated to have effects in other regions of the nervous system. Within the hippocampus, α-TOH induced long-term potentiation ([@bib67]), which is involved in learning and memory ([@bib58]). The action of vitE in hippocampal CA1 neurons occurred without a significant alteration in the membrane potential and the input resistance. Rats that are fed a vitE-deficient diet for three months had impaired long-term potential induction, with a reduction in post-tetanic potentiation, suggesting that either neurotransmitter release or postsynaptic mechanisms are involved ([@bib68]). It remains to be determined if the postulated mechanism for the neuroprotective effect of vitE in the DRG ([Figure 7](#fig7){ref-type="fig"}) is applicable to other regions of the nervous system.

In conclusion, we have identified the most profound transcriptomic, biochemical, and electrophysiologic changes in small-diameter TH+ mechanosensitive DRGNs, rather than the proprioceptive subpopulation, with vitE deficiency. Increased upregulation of voltage-gated Ca^2+^ and K^+^ channels led to AP abbreviation and reduced membrane excitability in TH+ DRGNs. Concurrently, alterations in IP~3~R1 expression were identified, in addition to evidence of apoptosis via caspase-3- and caspase-9-mediated pathways. A highly supplemented α-TOH diet rescues the cellular and molecular alterations and represses the loss of mechanosensation found in DEF mice. The peripheral neuropathy associated with AVED likely encompasses defects in membrane properties and Ca^2+^ signaling in mechanosensitive TH+ DRGNs, providing targets for therapeutic intervention.

Limitations of the Study {#sec3.1}
------------------------

We cannot determine from this study if the observed effects on membrane excitability are the result of the observed gene expression changes following vitE deficiency or the insufficient vitE concentrations in the DRGNs. Experiments requiring the addition of exogenous α-TOH to DRGNs from DEF mice would be required to determine if membrane excitability can be restored with the addition of vitE.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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